CERAD-neuropsychological battery in screening mild Alzheimer's disease.
about
Everyday cognition scales are related to cognitive function in the early stage of probable Alzheimer's disease and FDG-PET findingsMemory concerns, memory performance and risk of dementia in patients with mild cognitive impairment.Subtle neuropsychiatric and neurocognitive changes in hereditary gelsolin amyloidosis (AGel amyloidosis).English Longitudinal Study of Aging: can Internet/E-mail use reduce cognitive decline?The Progression of Alzheimer's Disease Can Be Assessed with a Short Version of the CERAD Neuropsychological Battery: The Kuopio ALSOVA StudyAssessing the discriminant ability, reliability, and comparability of multiple short forms of the Boston Naming Test in an Alzheimer's disease center cohort.Cognitive Ageing in Great Britain in the New Century: Cohort Differences in Episodic Memory.The Effect of Choline Acetyltransferase Genotype on Donepezil Treatment Response in Patients with Alzheimer's DiseaseCERAD Neuropsychological Total Scores Reflect Cortical Thinning in Prodromal Alzheimer's DiseaseDetailed cognitive function and use of drugs with anticholinergic properties in older people: a community-based cross-sectional study.Socioeconomic and lifestyle factors related to instrumental activity of daily living dynamics: results from the English Longitudinal Study of Ageing.The CERAD Neuropsychological Battery in Patients with Frontotemporal Lobar DegenerationDiagnostic accuracy of CERAD total score in a Colombian cohort with mild cognitive impairment and Alzheimer's disease affected by E280A mutation on presenilin-1 gene.Detecting At-Risk Alzheimer's Disease Cases.CERAD test performance and cognitive impairment in Parkinson's disease.Psychometric evaluation of ADAS-Cog and NTB for measuring drug response.Diagnostic Accuracy of Memory Measures in Alzheimer's Dementia and Mild Cognitive Impairment: a Systematic Review and Meta-Analysis.Screening for Alzheimer's Disease: Cognitive Impairment in Self-Referred and Memory Clinic-Referred Patients.Low cortical iron and high entorhinal cortex volume promote cognitive functioning in the oldest-old.Attention and CERAD test performances in cognitively impaired elderly subjects.Recognition memory is associated with altered resting-state functional connectivity in people at genetic risk for Alzheimer's disease.Serum thyroid-stimulating hormone and cognition in older people.Simultaneous quantitative susceptibility mapping and Flutemetamol-PET suggests local correlation of iron and β-amyloid as an indicator of cognitive performance at high age.
P2860
Q33687460-A9B009EB-77D8-4047-8B30-84324AFCB459Q33895227-3118BC65-DA91-4364-8857-DF4BA1A02FFEQ34001151-AF1D975C-DE0A-4628-AD1E-2C262391777CQ34366385-25E1B589-5FD5-4A8E-9551-F19976ECEE4DQ34975011-E49F145A-963D-4A5B-AB45-FD3BFA7A71B6Q35219395-1720A0B6-5C3C-4D6A-888C-3ACFD8629571Q35880479-D9261450-BF8F-4038-B0F4-95027A83E72EQ35965628-BE9DE7CF-368C-41DA-979D-812F627B6742Q37573631-024A7125-486C-4688-BA88-E16FBAB5B437Q38457002-A8A65A42-F995-4C54-BB70-6EFB1C5B5DF6Q40223780-52ECEA6C-0B38-45E9-8E37-6C6540C22819Q40917984-315DB1E6-C5BE-4F23-84F0-3B5DDCED931EQ41205194-63DBB6EC-021E-491F-A642-23C5E6002711Q41863951-5B024E7E-D90E-4B8B-A141-B4F2418CF9CBQ44998478-6FF63D7E-47E1-4758-891D-D049D34E2C67Q46094104-B713C26D-981E-4DBF-8445-F55A59565AB5Q46678949-88465394-9318-4B7F-9B0A-2B43723E6816Q47134237-DED5C840-D6E7-47ED-9FBB-5B61E6E695EEQ47851326-C8988328-B07F-48C8-AC0A-2986841647B3Q48184902-C9BB711E-8BEF-4E92-881E-A7CE9B2B9AB5Q48681380-B26EE94E-8F96-4C8D-9136-3703E3832DB4Q50957214-B0CE13BD-B179-4AC9-B53D-AA0F6E00A75CQ51762367-D01FF51B-FB27-4A1A-8100-8E4F5ACD2205
P2860
CERAD-neuropsychological battery in screening mild Alzheimer's disease.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
CERAD-neuropsychological battery in screening mild Alzheimer's disease.
@en
CERAD-neuropsychological battery in screening mild Alzheimer's disease.
@nl
type
label
CERAD-neuropsychological battery in screening mild Alzheimer's disease.
@en
CERAD-neuropsychological battery in screening mild Alzheimer's disease.
@nl
prefLabel
CERAD-neuropsychological battery in screening mild Alzheimer's disease.
@en
CERAD-neuropsychological battery in screening mild Alzheimer's disease.
@nl
P2093
P2860
P1476
CERAD-neuropsychological battery in screening mild Alzheimer's disease.
@en
P2093
I Hallikainen
L Hokkanen
M Sotaniemi
T Hänninen
T Pirttilä
V Pulliainen
P2860
P356
10.1111/J.1600-0404.2010.01459.X
P407
P577
2011-01-04T00:00:00Z